Walgreens Boots Alliance, Inc. (WBA) EV/Sales Ratio: 0.25x
Is Walgreens Boots Alliance, Inc.’s EV/Sales ratio high or low?
Walgreens Boots Alliance, Inc.'s EV/Sales ratio of 0.25x is 45% below its 5-year average of 0.45x, near the low end of its 5-year range (0.25x–0.69x).
As of Saturday, June 13, 2026. 5.35% below its 12-month average of 0.26x.
WBA EV/Sales Ratio Chart
WBA Average EV/Sales Ratio Chart
WBA Current vs Average EV/Sales Ratio Chart
WBA EV/Sales Ratio Metrics
EV/SALES RATIO
0.25x
EV/SALES RATIO AVG TTM
0.26x
EV/SALES RATIO AVG 3Y
0.37x
EV/SALES RATIO AVG 5Y
0.45x
EV/SALES RATIO AVG 10Y
0.59x
EV/SALES RATIO AVG 15Y
0.62x
EV/SALES RATIO AVG 20Y
0.65x
CURRENT VS TTM AVG
-5.35%
CURRENT VS 3Y AVG
-31.99%
CURRENT VS 5Y AVG
-44.96%
CURRENT VS 10Y AVG
-57.35%
CURRENT VS 15Y AVG
-59.81%
CURRENT VS 20Y AVG
-61.33%
WBA Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 0.25x | 0.26x | 0.37x | 0.45x |
| Baxter International Inc. (BAX) | $10.77B | 1.63x | 1.72x | 2.17x | 2.64x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 2.99x | 2.79x | 3.02x | 3.79x |
| Tempus AI, Inc. (TEM) | $8.35B | 6.49x | 11.43x | 12.17x | 12.17x |
| Align Technology, Inc. (ALGN) | $12.52B | 2.83x | 2.73x | 4.07x | 5.90x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 3.31x | 3.41x | 3.67x | 4.57x |
| The Cooper Companies, Inc. (COO) | $13.24B | 3.68x | 4.15x | 5.16x | 5.81x |
| Solventum Corporation (SOLV) | $13.66B | 2.22x | 2.19x | 2.26x | 2.26x |
| Hims & Hers Health, Inc. (HIMS) | $5.98B | 2.97x | 4.71x | 4.20x | 4.27x |
| Hologic, Inc. (HOLX) | $16.97B | 4.25x | 4.02x | 4.39x | 4.15x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Walgreens Boots Alliance, Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Walgreens Boots Alliance, Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The EV/Sales ratio for WBA stock is 0.25x.
- Is Walgreens Boots Alliance, Inc.'s EV/Sales ratio high or low?
- Walgreens Boots Alliance, Inc.'s EV/Sales ratio of 0.25x is 45% below its 5-year average of 0.45x, near the low end of its 5-year range (0.25x–0.69x).
- What is the TTM average EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The TTM average EV/Sales ratio for WBA stock is 0.26x.
- What is the 3Y average EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 3Y average EV/Sales ratio for WBA stock is 0.37x.
- What is the 5Y average EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 5Y average EV/Sales ratio for WBA stock is 0.45x.
- What is the 10Y average EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 10Y average EV/Sales ratio for WBA stock is 0.59x.
- What is the 15Y average EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 15Y average EV/Sales ratio for WBA stock is 0.62x.
- What is the 20Y average EV/Sales ratio for Walgreens Boots Alliance, Inc. (WBA)?
- The 20Y average EV/Sales ratio for WBA stock is 0.65x.
Walgreens Boots Alliance, Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2025-08-28 | 0.25x |
| 2025-08-27 | 0.25x |
| 2025-08-26 | 0.25x |
| 2025-08-25 | 0.25x |
| 2025-08-22 | 0.25x |
| 2025-08-21 | 0.25x |
| 2025-08-20 | 0.25x |
| 2025-08-19 | 0.25x |
| 2025-08-18 | 0.25x |
| 2025-08-15 | 0.25x |
| 2025-08-14 | 0.25x |
| 2025-08-13 | 0.25x |
| 2025-08-12 | 0.25x |
| 2025-08-11 | 0.25x |
| 2025-08-08 | 0.25x |
| 2025-08-07 | 0.25x |
| 2025-08-06 | 0.25x |
| 2025-08-05 | 0.25x |
| 2025-08-04 | 0.25x |
| 2025-08-01 | 0.25x |
| 2025-07-31 | 0.25x |
| 2025-07-30 | 0.25x |
| 2025-07-29 | 0.25x |
| 2025-07-28 | 0.25x |
| 2025-07-25 | 0.25x |
| 2025-07-24 | 0.25x |
| 2025-07-23 | 0.25x |
| 2025-07-22 | 0.25x |
| 2025-07-21 | 0.25x |
| 2025-07-18 | 0.25x |
| 2025-07-17 | 0.25x |
| 2025-07-16 | 0.25x |
| 2025-07-15 | 0.25x |
| 2025-07-14 | 0.25x |
| 2025-07-11 | 0.25x |
| 2025-07-10 | 0.25x |
| 2025-07-09 | 0.25x |
| 2025-07-08 | 0.25x |
| 2025-07-07 | 0.25x |
| 2025-07-03 | 0.25x |
| 2025-07-02 | 0.25x |
| 2025-07-01 | 0.25x |
| 2025-06-30 | 0.25x |
| 2025-06-27 | 0.25x |
| 2025-06-26 | 0.25x |
| 2025-06-25 | 0.26x |
| 2025-06-24 | 0.26x |
| 2025-06-23 | 0.26x |
| 2025-06-20 | 0.26x |
| 2025-06-18 | 0.26x |
| 2025-06-17 | 0.26x |
| 2025-06-16 | 0.26x |
| 2025-06-13 | 0.26x |
| 2025-06-12 | 0.26x |
| 2025-06-11 | 0.26x |
| 2025-06-10 | 0.26x |
| 2025-06-09 | 0.26x |
| 2025-06-06 | 0.26x |
| 2025-06-05 | 0.26x |
| 2025-06-04 | 0.26x |
| 2025-06-03 | 0.26x |
| 2025-06-02 | 0.26x |
| 2025-05-30 | 0.26x |
| 2025-05-29 | 0.26x |
| 2025-05-28 | 0.26x |
| 2025-05-27 | 0.26x |
| 2025-05-23 | 0.26x |
| 2025-05-22 | 0.26x |
| 2025-05-21 | 0.26x |
| 2025-05-20 | 0.26x |
| 2025-05-19 | 0.26x |
| 2025-05-16 | 0.26x |
| 2025-05-15 | 0.26x |
| 2025-05-14 | 0.26x |
| 2025-05-13 | 0.26x |
| 2025-05-12 | 0.26x |
| 2025-05-09 | 0.26x |
| 2025-05-08 | 0.26x |
| 2025-05-07 | 0.26x |
| 2025-05-06 | 0.26x |
| 2025-05-05 | 0.26x |
| 2025-05-02 | 0.26x |
| 2025-05-01 | 0.26x |
| 2025-04-30 | 0.26x |
| 2025-04-29 | 0.26x |
| 2025-04-28 | 0.26x |
| 2025-04-25 | 0.26x |
| 2025-04-24 | 0.26x |
| 2025-04-23 | 0.26x |
| 2025-04-22 | 0.26x |
| 2025-04-21 | 0.26x |
| 2025-04-17 | 0.26x |
| 2025-04-16 | 0.26x |
| 2025-04-15 | 0.26x |
| 2025-04-14 | 0.26x |
| 2025-04-11 | 0.26x |
| 2025-04-10 | 0.25x |
| 2025-04-09 | 0.26x |
| 2025-04-08 | 0.25x |
| 2025-04-07 | 0.26x |
| 2025-04-04 | 0.26x |
| 2025-04-03 | 0.26x |
| 2025-04-02 | 0.26x |
| 2025-04-01 | 0.26x |
| 2025-03-31 | 0.26x |
| 2025-03-28 | 0.26x |
| 2025-03-27 | 0.26x |
| 2025-03-26 | 0.26x |
| 2025-03-25 | 0.26x |
| 2025-03-24 | 0.26x |
| 2025-03-21 | 0.26x |
| 2025-03-20 | 0.26x |
| 2025-03-19 | 0.26x |
| 2025-03-18 | 0.26x |
| 2025-03-17 | 0.26x |
| 2025-03-14 | 0.26x |
| 2025-03-13 | 0.26x |
| 2025-03-12 | 0.26x |
| 2025-03-11 | 0.26x |
| 2025-03-10 | 0.26x |
| 2025-03-07 | 0.26x |
| 2025-03-06 | 0.26x |
| 2025-03-05 | 0.26x |
| 2025-03-04 | 0.26x |
| 2025-03-03 | 0.26x |
| 2025-02-28 | 0.26x |
| 2025-02-27 | 0.26x |
| 2025-02-26 | 0.26x |
| 2025-02-25 | 0.26x |
| 2025-02-24 | 0.26x |
| 2025-02-21 | 0.26x |
| 2025-02-20 | 0.26x |
| 2025-02-19 | 0.26x |
| 2025-02-18 | 0.26x |
| 2025-02-14 | 0.25x |
| 2025-02-13 | 0.25x |
| 2025-02-12 | 0.25x |
| 2025-02-11 | 0.25x |
| 2025-02-10 | 0.26x |
| 2025-02-07 | 0.26x |
| 2025-02-06 | 0.26x |
| 2025-02-05 | 0.26x |
| 2025-02-04 | 0.26x |
| 2025-02-03 | 0.25x |
| 2025-01-31 | 0.26x |
| 2025-01-30 | 0.26x |
| 2025-01-29 | 0.26x |
| 2025-01-28 | 0.26x |
| 2025-01-27 | 0.26x |
| 2025-01-24 | 0.27x |
| 2025-01-23 | 0.27x |
| 2025-01-22 | 0.27x |
| 2025-01-21 | 0.26x |
| 2025-01-17 | 0.27x |
| 2025-01-16 | 0.27x |
| 2025-01-15 | 0.27x |
| 2025-01-14 | 0.27x |
| 2025-01-13 | 0.27x |
| 2025-01-10 | 0.27x |
| 2025-01-08 | 0.27x |
| 2025-01-07 | 0.28x |
| 2025-01-06 | 0.28x |
| 2025-01-03 | 0.28x |
| 2025-01-02 | 0.27x |
| 2024-12-31 | 0.27x |
| 2024-12-30 | 0.27x |
| 2024-12-27 | 0.28x |
| 2024-12-26 | 0.28x |
| 2024-12-24 | 0.27x |
| 2024-12-23 | 0.27x |
| 2024-12-20 | 0.28x |
| 2024-12-19 | 0.27x |
| 2024-12-18 | 0.28x |
| 2024-12-17 | 0.28x |
| 2024-12-16 | 0.28x |
| 2024-12-13 | 0.28x |
| 2024-12-12 | 0.28x |
| 2024-12-11 | 0.28x |
| 2024-12-10 | 0.28x |
| 2024-12-09 | 0.27x |
| 2024-12-06 | 0.27x |
| 2024-12-05 | 0.27x |
| 2024-12-04 | 0.27x |
| 2024-12-03 | 0.27x |
| 2024-12-02 | 0.27x |
| 2024-11-29 | 0.27x |
| 2024-11-27 | 0.27x |
| 2024-11-26 | 0.27x |
| 2024-11-25 | 0.27x |
| 2024-11-22 | 0.27x |
| 2024-11-21 | 0.27x |
| 2024-11-20 | 0.27x |
| 2024-11-19 | 0.27x |
| 2024-11-18 | 0.27x |
| 2024-11-15 | 0.27x |
| 2024-11-14 | 0.27x |
| 2024-11-13 | 0.27x |
| 2024-11-12 | 0.27x |
| 2024-11-11 | 0.27x |
| 2024-11-08 | 0.27x |
| 2024-11-07 | 0.27x |
| 2024-11-06 | 0.27x |
| 2024-11-05 | 0.28x |
| 2024-11-04 | 0.27x |
| 2024-11-01 | 0.28x |
| 2024-10-31 | 0.28x |
| 2024-10-30 | 0.27x |
| 2024-10-29 | 0.27x |
| 2024-10-28 | 0.27x |
| 2024-10-25 | 0.27x |
| 2024-10-24 | 0.27x |
| 2024-10-23 | 0.27x |
| 2024-10-22 | 0.28x |
| 2024-10-21 | 0.28x |
| 2024-10-18 | 0.28x |
| 2024-10-17 | 0.28x |
| 2024-10-16 | 0.28x |
| 2024-10-15 | 0.28x |
| 2024-10-14 | 0.28x |
| 2024-10-11 | 0.28x |
| 2024-10-10 | 0.28x |
| 2024-10-09 | 0.28x |
| 2024-10-08 | 0.28x |
| 2024-10-07 | 0.28x |
| 2024-10-04 | 0.28x |
| 2024-10-03 | 0.28x |
| 2024-10-02 | 0.28x |
| 2024-10-01 | 0.28x |
| 2024-09-30 | 0.28x |
| 2024-09-27 | 0.28x |
| 2024-09-26 | 0.28x |
| 2024-09-25 | 0.28x |
| 2024-09-24 | 0.28x |
| 2024-09-23 | 0.28x |
| 2024-09-20 | 0.28x |
| 2024-09-19 | 0.28x |
| 2024-09-18 | 0.28x |
| 2024-09-17 | 0.28x |
| 2024-09-16 | 0.28x |
| 2024-09-13 | 0.28x |
| 2024-09-12 | 0.28x |
| 2024-09-11 | 0.28x |
| 2024-09-10 | 0.28x |
| 2024-09-09 | 0.28x |
| 2024-09-06 | 0.28x |
| 2024-09-05 | 0.28x |
| 2024-09-04 | 0.28x |
| 2024-09-03 | 0.28x |
| 2024-08-30 | 0.28x |
| 2024-08-29 | 0.28x |
| 2024-08-28 | 0.28x |
| 2024-08-27 | 0.28x |
| 2024-08-26 | 0.29x |
| 2024-08-23 | 0.29x |
| 2024-08-22 | 0.29x |
| 2024-08-21 | 0.29x |
| 2024-08-20 | 0.29x |
| 2024-08-19 | 0.29x |
| 2024-08-16 | 0.29x |
| 2024-08-15 | 0.29x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth